MAY 12, 2019 3:11 PM PDT

Potential of Statins to Treat Multiple Sclerosis

WRITTEN BY: Nouran Amin

health.harvard.edu

A widely used therapeutic statin, simvastatin, which is intended to treat cholesterol was found to be medically beneficial for patients with secondary progressive Multiple Sclerosis (SPMS).

"Although this study cannot provide a final answer as to what exactly is the reason for the success of statins in progressive MS, it directs future researchers toward certain pathways," said lead author, Dr Arman Eshaghi (UCL Queen Square Institute of Neurology). "This paves the way to find better drug targets for an incurable disease such as MS."

Generally, multiple sclerosis (MS) affects how people walk, move, see, think, and feel and there is currently no cure for MS with little effective treatment for the secondary form.

Learn more about Multiple Sclerosis (MS):

The study, published in Proceedings of the National Academy of Sciences (PNAS), simvastatin was reanalyzed from earlier studies of Multiple Sclerosis-Statins trial data. The analysis resulted in a hypothesis that causal associations between simvastatin and the brain changes it leads to are a result of either directly or indirectly changing the patient's peripheral cholesterol level.

"Simvastatin is one of the most promising treatment prospects for secondary progressive MS in our lifetime. People with this form of the condition have been waiting decades for a drug that works, which is why there's such excitement around being able to start the trial," said Professor Chataway, who is leading the trial and is a co-author on the PNAS paper.

To examine if a reduction in cholesterol levels resulted in a positive impact on brain atrophy and on disability, two computational models were developed—a cholesterol-mediated model and a cholesterol-independent model. In the cholesterol-mediated model, the effects of simvastatin on clinical measures and brain atrophy were brought by changes in cholesterol. The cholesterol-independent model, simvastatin was shown to have a direct effect on the clinical and MRI outcome measures that are independent of the effects on serum cholesterol levels.

"Statins are naturally occurring, produced by some fungi, meaning that unlike most drugs that are designed for specific targets, they have (still after two decades of use in heart diseases) several unknown effects, and that is why this study is so important,” says Dr Eshaghi. "My study tells us that statins help patients with MS for reasons different from how they help people lower their cholesterol. For example, statins can modulate other elements that are produced in the pathways before cholesterol, but have indirect effects on the immune system."

Source: Science Daily

 

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JUL 01, 2020
Health & Medicine
New Venture Will Commercialize Products From Cannabis Research
JUL 01, 2020
New Venture Will Commercialize Products From Cannabis Research
Though the history of cannabis dates back at least three thousand years, the workings of the endocannabinoid system-the ...
JUL 17, 2020
Cancer
Tackling the Problem of Toxicity in Breast Cancer Therapy
JUL 17, 2020
Tackling the Problem of Toxicity in Breast Cancer Therapy
Chemotherapy has been one of the primary methods of cancer treatment for decades. Usually, a doctor applies a chemothera ...
JUL 17, 2020
Immunology
More Potential Antibody Therapies for COVID Emerge
JUL 17, 2020
More Potential Antibody Therapies for COVID Emerge
When it comes to clinical countermeasures against COVID-19, one class of molecules stands out among the others: antibodi ...
JUL 23, 2020
Cardiology
Protecting the Heart After a Heart Attack
JUL 23, 2020
Protecting the Heart After a Heart Attack
Cardiovascular disease accounts for thirty percent of mortalities around the world. These diseases start small and slowl ...
JUL 13, 2020
Drug Discovery & Development
Potential Therapy for The Dengue Virus
JUL 13, 2020
Potential Therapy for The Dengue Virus
Researchers at the University of Texas Medical Branch at Galveston have uncovered a new antiviral mechanism for the new ...
AUG 04, 2020
Drug Discovery & Development
Erectile Dysfunction Drug Cures Critical COVID-19 Patients
AUG 04, 2020
Erectile Dysfunction Drug Cures Critical COVID-19 Patients
Critically ill patients who received COVID-19 drug candidate aviptadil (RLF-100) were able to make a rapid recovery from ...
Loading Comments...